Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

CRF can cause hair loss, but blocking its receptors might prevent this.

CRH causes hair loss by reducing autophagy and increasing cell death in hair cells.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

GnRH treatment can reduce breast cancer cell invasion.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

TAK-279 effectively reduces psoriasis symptoms and is safe.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

A CCS patient with severe complications was successfully treated using combined therapies.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

ATP-sensitive potassium channels play a role in chloroquine-induced itch in mice.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.